NCT01232010View on ClinicalTrials.gov

Clinical Study to Investigate the Safety and Pharmacokinetics of SK3530 Tablet in Renal Impaired Male Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

December 31, 2011

Conditions
Renal InsufficiencyKidney DiseasesUrologic Diseases
Interventions
DRUG

Mirodenafil

50mg Single Oral Dose of

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

SK Chemicals Co., Ltd.

INDUSTRY

lead

Asan Medical Center

OTHER

NCT01232010 - Clinical Study to Investigate the Safety and Pharmacokinetics of SK3530 Tablet in Renal Impaired Male Patients | Biotech Hunter | Biotech Hunter